Publications by authors named "Shiro Tara"

Claim this Profile
P
PRC2 insufficiency causes p53-dependent dyserythropoiesis in myelodysplastic syndrome.
Kazumasa Aoyama, Daisuke Shinoda, Emi Suzuki, Yaeko Nakajima-Takagi, Motohiko Oshima, Shiro Tara

Leukemia· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
insufficiency promotes initiation and progression of myelodysplastic syndrome.
Shiro Tara, Yusuke Isshiki, Yaeko Nakajima-Takagi, Motohiko Oshima, Kazumasa Aoyama

Blood· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome.
Kazumasa Aoyama, Motohiko Oshima, Shuhei Koide, Emi Suzuki, Makiko Mochizuki-Kashio, Shiro Tara

iScience· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies.
Tomoyuki Tanaka, Yaeko Nakajima-Takagi, Kazumasa Aoyama, Shiro Tara, Motohiko Oshima

J Exp Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
Masayuki Yokoyama, Tetsuhiro Chiba, Yoh Zen, Motohiko Oshima, Yuko Kusakabe, Shiro Tara

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis